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ABSTRACT 
One of the major issues concerning human skeletal muscle progenitor cells is represented by the 
efficient isolation and in vitro expansion of cells retaining the ability to proliferate, migrate and 
differentiate once transplanted. Here we describe a method i) effective in obtaining human muscle 
precursor cells both from fresh and frozen biopsies coming from different muscles, ii) selective to 
yield cells uniformly positive for CD56 and negative for CD34 without FACS sorting, iii) reliable 
in maintaining proliferative and in vitro differentiative capacity up to passage 10.  
 
Key words: human muscle precursor cells, skeletal muscle biopsy, CD56, enzymatic digestion, 
human muscle cell primary culture.  
 
1. INTRODUCTION 
Two main approaches are currently employed for the obtainment of myogenic precursor cells, 
namely single fiber isolation, firstly described by Rosenblatt and colleagues [1] and applied also for 
human samples [2], and whole muscle enzymatic digestion with different adaptations [3,4]. The 
first method allows to get a virtually pure population of activate satellite cells but is a quite complex 
procedure, starting from the muscle collection which has to provide myofibers preserved in their 
length, whereas the second one is more simple and fast but yields a mixed cell population and 
usually need further passages such as preplating or fluorescence-activated cell sorting [5,6]. In 
terms of surface antigen expression, different proteins have been investigate to better define the 
precursor cells in human muscle, however so far the literature is quite unanimous in identifying the 
cells restricted to a myogenic fate in the CD56+CD34- population [7,8].  
Here we described a protocol to efficiently isolate and expand in culture human muscle precursor 
cells from different skeletal muscles through a whole muscle digestion method without the need of 
further cell processing. This is possible following the combination of (i) careful biopsy collection 
and cleaning, (ii) double enzymatic digestion, (iii) defined medium composition and appropriate 
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plastic ware. This method allows obtaining homogeneous CD56+CD34- cell population that 
maintain proliferative and in vitro differentiative capacity up to passage 10. Moreover, although 
other improvements mainly regarding culture conditions are needed in the perspective of a future 
possible clinical application, we defined a freezing procedure that does not affect cell isolation and 
characteristics. 
 
2. MATERIALS 
2.1 Culture media and plastic ware 
1. Prepare the Collagenase I 0.2% (w/v) solution: weigh 200 mg of lyophilized Collagenase 
from Clostridium histolyticum for general use, Type I (Sigma Aldrich) and resuspend with 2 
mL of DMEM 1X 1 g/L glucose (+) L-Glutamine (+) Pyruvate (GIBCO, Thermo Fisher 
Scientific), then add 98 mL of DMEM. Filter the solution through a 0.22 µm filter and stock 
single-use aliquots at -20°C. 
2. Trypsin 0.05 % with EDTA and Phenol Red (GIBCO, Thermo Fisher Scientific). 
3. Red blood cell lysis buffer: Auto Lyse Plus (Biosource). 
4. Washing medium: DMEM 1X 1 g/L glucose (+) L-Glutamine (+) Pyruvate containing 20% 
fetal bovine serum (FBS) (GIBCO, Thermo Fisher Scientific) and 1% Penicillin 
Streptomicin (pen/strep) (GIBCO, Thermo Fisher Scientific). 
5. Proliferation medium: DMEM 1X 1 g/L glucose (+) L-Glutamine (+) Pyruvate containing 
20% FBS, 10-6 M dexamethasone (Sigma Aldrich), 10 ng/mL recombinant mouse FGF 
basic protein (R&D Systems), 10 µg/mL insulin (Insuman Rapid 100UI/mL, Sanofi 
Aventis) and 1% pen/strep. 
6. Differentiation medium: MEM Alpha (1X), (+) L-Glutamine, (+) Ribonucleosides, (+) 
Deoxyribonucleosides, (-) Ascorbic Acid (GIBCO, Thermo Fisher Scientific) containing 2% 
horse serum (GIBCO, Thermo Fisher Scientific), 10 µg/mL insulin and 1% pen/strep. 
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7. Freezing medium: 70% FBS, 10% DMEM 1X 4.5 g/L glucose (+) L-Glutamine (+) Pyruvate 
(GIBCO, Thermo Fisher Scientific), 20% dimethyl sulfoxide. 
8. Non-Tissue Culture Treated (NTC) Plate, polystyrene, flat bottom: 96-well, 24-well and 6-
well plates (Falcon, Corning). Use these plates for cell expansion and proliferating cell 
characterization. 
9. Non-Tissue Culture (NTC) polystyrene Petri dishes, 100 x 20 mm and 150 x 25 mm 
(Falcon, Corning). Use these plates for cell expansion. 
10. Tissue Culture Treated (TC) Plate, polystyrene, flat bottom: 24-well plates (Falcon, 
Corning). Use these plates for myogenic differentiation. 
2.2 Flow cytometry analysis 
1. Tubes or other supports suitable for your cytometer. 
2. Antibodies anti-human antigens: CD34-FITC clone 581, CD56-PE clone B159, 7-
aminoactinomycin D (7AAD) (all from BD Pharmigen). Isotype controls: mouse IgG1-
FITC (IOTest Immunotech), PE mouse anti-human Ig k (BD Pharmigen). 
2.3 Immunofluorescence analysis 
1. Routine reagents: 4% paraformaldehyde (PFA) for fixation, 0.5% Triton-X100 in 
phosphate-buffered saline (PBS) for permeabilization, 10% horse serum in PBS for 
saturation, 1% bovine serum albumin (BSA) in PBS for antibodies dilution, 4',6-diamidino-
2-phenylindole (DAPI) fluorescence mounting medium for nuclei counterstaining. 
2. Proliferating cell characterization. Primary antibodies: monoclonal rabbit IgG anti-human 
Ki-67 clone SP6 (Novusbio), monoclonal mouse IgG1 anti-human PAX7 clone PAX7 (R&D 
systems), polyclonal rabbit IgG anti-human MYOD clone M318 (Santa Cruz 
Biotechnology), polyclonal rabbit IgG anti-human MYF5 clone C20 (Santa Cruz 
Biotechnology). Secondary antibodies: chicken anti-rabbit IgG (H+L) Alexa Fluor® 594 
conjugate (Thermo Fisher Scientific), goat anti-mouse IgG (H+L) Alexa Fluor® 594 
conjugate (Thermo Fisher Scientific). 
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3. Differentiated cell characterization. Primary antibody: monoclonal mouse IgG2B anti-human 
Myosin Heavy Chain clone MF20 (R&D systems). Secondary Antibody: goat anti-mouse 
IgG (H+L) Alexa Fluor® 594 conjugate (Thermo Fisher Scientific). 
 
3. METHODS 
3.1 Cell isolation  
1. Carry the muscle biopsy (see Note 1, Fig. 1 and Fig. 2) in sterile saline from operating 
theatre to the laboratory cell processing room (see Note 2). 
2. Transfer the sample on a Petri dish using disposable sterile plastic pincers and quickly rinse 
it with Betadine® or similar products and PBS. 
3. Transfer the sample in a clean Petri dish and carefully remove visible vasculature, 
connective tissue and potential adipose tissue (see Note 3).  
4. Divide the muscle in pieces weighting up to 500 mg (see Note 4) and treat every piece 
separately. 
5. Mince the sample in very small pieces (1-2 mm3) using two disposable sterile scalpels.  
6. Cover minced sample with 3 mL of 0.2% (w/v) Collagenase I in a well of 6-well plate and 
incubate for 90 min at 37°C. 
7. Transfer the digestion product in a 15 mL conical centrifuge tube, add 10 mL of washing 
medium and homogenate with serological pipette, then centrifuge at 300 x g for 10 min. 
8. Take out the supernatant and resuspend the pellet with 2 mL of 0.05 % Trypsin-EDTA, 
transfer in a well of 6-well plate and incubate for 60 min at 37°C. 
9. Transfer the digestion product in a 15 mL conical centrifuge tube, add 10 mL of washing 
medium and homogenate with serological pipette, then filter twice the cell suspension first 
through 70 µm and then 40 µm cell strainers. Centrifuge at 300 x g for 10 min. 
10. Resuspend the pellet in 3 mL red blood cell lysis buffer for 5 min, add 10 mL of washing 
medium and centrifuge at 300 x g for 10 min. 
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11. Resuspend the pellet in 2 mL of proliferation medium and seed cells in a well of 6-well NTC 
plate. 
12. Refresh proliferation medium after 48-72 hours (see Note 5). Usually attached cells appear 
after 5-7 days from enzymatic digestion (see Note 6). 
3.2 Sample freezing 
1. Transfer minced sample obtained at step 5 of section 3.1 in a 2 mL cryovial and add 1 mL 
of freezing medium.  
2. Proceed with slow cooling protocol as for cell samples and store in liquid nitrogen (see Note 
7). 
3.3 Sample thawing 
1. Take out sample from liquid nitrogen and thaw in water bath at 37°C. 
2. Transfer sample in a 15 mL conical centrifuge tube, add 10 mL of washing medium and 
centrifuge at 300 x g for 10 min.  
3. Proceed with step 6 of section 3.1. 
3.4 Cell expansion 
1. Take out the medium from the well or dish and wash twice with PBS. Add the appropriate 
volume of 0.05 % Trypsin-EDTA (300 µL for wells of 6-well plate, 1 mL for 100 x 20 mm 
dishes, 2 mL for 150 x 25 mm dishes) and incubate for 5-10 min at 37°C.  
2. Add washing medium, collect detached cells and centrifuge at 300 x g for 10 min. Remove 
the supernatant, resuspend cell pellet in proliferation medium and seed cells on a suitable 
NTC well or dish. Usually around 1 x 105 cells in a 100 x 20 mm dish and 2.5 x 105 cells in 
a 150 x 25 mm dish are seeded. We recommend never exceeding the 60-70% of confluence. 
In our experience cells maintain unaltered characteristics up to passage 10. 
3.5 Cell characterization 
1. Doubling time analysis (Fig. 3A): seed 1 x 104 cells for each well of 24-well NTC plate in 
proliferation medium, after 48 h detach cells by trypsin treatment and proceed with 
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counting. Consider at least three wells separately. Calculate the doubling time (g) using the 
following equation g = 48 h x [log 2 / log (N48h/N0)] in which g is the generation (or 
doubling) time during the logarithmic phase of the growth curve, N48h is the cell number at 
48 h after seeding and N0 is the cell number at time 0 [9]. 
2. Flow cytometry analysis (Fig. 3B): detach cells by trypsin treatment and proceed with 
incubation using antibodies described in the Materials 2.2 section. Usually we observe 
more than 90% of CD56 positive cells and no cells positive for CD34. 
3. Immunofluorescence analysis of proliferating cells (Fig. 3C-D): seed 5 x 103 cells for each 
well of 96-well NTC plate in proliferation medium, after 48 h take out the culture medium, 
wash twice with PBS and fix cells by incubation with 4% PFA at 4°C for 10 min. Proceed 
with the immunostaining protocol using the antibodies described in the Materials 2.3 
section paragraph 2. 
4. Myogenic differentiation and myogenic index evaluation (Fig. 3E): seed 1.5 x 104 cells for 
each well of 24-well TC plate in proliferation medium and let cells proliferate for 48 h, then 
take out the medium and add differentiation medium. After 48 h refresh differentiation 
medium and after other 48 h take out the medium, wash twice with PBS and fix cells by 
incubation with 4% PFA at 4°C for 10 min. Proceed with the immunostaining protocol using 
the antibodies described in the Materials 2.3 section paragraph 3. Calculate the myogenic 
index defined as the number of nuclei residing in cells containing three or more nuclei 
divided by the total number of nuclei [10]. Consider at least 5 fields at 20X magnification 
for each sample. 
 
4. NOTES 
1. We experienced efficient isolation and expansion of muscle precursor cells starting from 
biopsies obtained from different adult skeletal muscle listed in Fig. 1. We also applied our 
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method to pediatric abdominal muscle biopsies and derived muscle precursor cells with 
similar features to those observed in cells of adult origin (described in Fig. 3). 
2. If it is not possible to process the biopsy immediately after surgery it can be maintained in 
sterile saline at 4°C not longer than 24 hours. 
3. We considered biopsies from adult healthy subjects aged from 25 to 60 years undergoing 
scheduled orthopedic operations or surgery after trauma, with muscle being virtually free of 
ectopic adipose tissue deposition that is instead present during aging or in some pathological 
condition [11]. 
4. For samples weighting less than 200 mg adjust reagent volumes and plastic ware as 
following:  
- 1.5 mL of 0.2% Collagenase I in a well of 24-well plate (step 6 of section 3.1) 
- 1 mL of 0.05% Trypsin-EDTA in a well of 24-well plate (step 8 of section 3.1) 
- avoid incubation with red blood cells lysis buffer (step 10 of section 3.1) 
- seed cells in 1 mL of proliferation medium in a well of 24-well NTC plate (step 11 of 
section 3.1) 
In case of small samples attached cells could appear slightly later (7-10 days). 
5. Despite of washing and filtering procedures it is possible to still observe cell and fiber debris 
at this stage, we thus recommend taking out medium and washing cells with PBS or 
washing medium before adding fresh proliferation medium.  
6. If attached cells appear before 5 days, it is possible that fibroblasts overcame the 
proliferation of myogenic cells. This may occur despite the careful removal of connective 
tissue from biopsies and an accurate muscle sample collection during surgery can help in 
avoiding this inconvenience. Although the large and granular appearance of fibroblasts is 
easily distinguishable from the elongated and thin shape of myogenic cells, we recommend 
performing flow cytometry analysis at earlier passage as possible to evaluate the percentage 
of CD56 positive cells.  
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7. In our experience there are not differences between freshly processed and frozen/thawed 
biopsies, apart a possible delay in the appearance of attached cells. 
8. Both adult and pediatric biopsies were taken after approval by local ethical committee and 
informed consent acceptance by patients (Prot N. 2682P and 3030P, Azienda Ospedaliera di 
Padova).  
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FIGURE LEGENDS 
Fig. 1 Muscle sources. Biopsies were obtained from different skeletal muscles, as highlighted in 
pink in the illustration; the numbers of samples analyzed for each muscle are listed in the table. 
Fig. 2 Method outline. After washing and removal of non-muscle tissue (1) samples are directly 
subject to enzymatic digestion (2.1) or frozen for later use (2.2). Isolated cells are cultured for 
several passages (3) and characterized in terms of surface antigen expression, proliferation, 
myogenic marker expression and myogenic index (4). 
Fig. 3 Cell characterization. A) Representative image of cell appearance in culture at phase 
contrast microscope (scale bar = 100µm) and bar graph of doubling time calculated at different 
passages. B) Representative dot-plot of expanded cells (passage 5) analyzed for the expression of 
CD56 and CD34 and bar graph of CD56 expression at different passages. C) Representative 
pictures of Ki67 and myogenic markers expression (passage 5) (scale bar = 100µm). D) Percentage 
of cells positive for Ki67 and myogenic markers at different passages (at least 5 fields for each 
independent experiment). E) Representative picture of myosin heavy chain staining (passage 5) 
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(scale bar = 100µm) and myogenic index calculation at different passages (at least 5 fields for each 
independent experiment). 
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